3,4-methylenedioxyamphetamine has been researched along with Cancer of Cervix in 1 studies
3,4-Methylenedioxyamphetamine: An amphetamine derivative that inhibits uptake of catecholamine neurotransmitters. It is a hallucinogen. It is less toxic than its methylated derivative but in sufficient doses may still destroy serotonergic neurons and has been used for that purpose experimentally.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Uganda has high incidence rates of cervical cancer (47." | 1.91 | "We Shall Tell them with Love, Inform them what we have Learnt and then Allow them to go" - Men's Perspectives of Self-Collected Cervical Cancer Screening in Rural Uganda: A Qualitative Inquiry. ( Mitchell-Foster, S; Mithani, N; Nakisige, C; Namugosa, R; Ogilvie, G; Orem, J; Payne, B; Rawat, A; Sanders, C, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rawat, A | 1 |
| Mithani, N | 1 |
| Sanders, C | 1 |
| Namugosa, R | 1 |
| Payne, B | 1 |
| Mitchell-Foster, S | 1 |
| Orem, J | 1 |
| Ogilvie, G | 1 |
| Nakisige, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Integrated Cervical Cancer Screening in Mayuge District Uganda (ASPIRE Mayuge): A Pragmatic Cluster Randomized Control Trial[NCT04000503] | 2,019 participants (Actual) | Interventional | 2019-08-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for 3,4-methylenedioxyamphetamine and Cancer of Cervix
| Article | Year |
|---|---|
"We Shall Tell them with Love, Inform them what we have Learnt and then Allow them to go" - Men's Perspectives of Self-Collected Cervical Cancer Screening in Rural Uganda: A Qualitative Inquiry.
Topics: Early Detection of Cancer; Female; Humans; Love; Male; Mass Screening; Men; Qualitative Research; Ru | 2023 |